Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

Tecan Journal dot

Selected category: FluentControl

Back to overview

Taking a Fluent® approach to genetic screening

Clinical diagnostics company Ambry Genetics focuses on the identification of germline mutations, detecting large deletions and duplications primarily by next generation sequencing. Automation holds the key to efficient high throughput assays, ensuring optimum productivity.

Read more

Stem cell research offers muscular dystrophy hope

Access to human pluripotent embryonic stem cells is enabling Genea Biocells to pioneer novel therapies to treat a number of neuromuscular diseases. Drawing on almost 30 years of research heritage, the company is using its expertise to model spinal muscular atrophy and facioscapulohumeral muscular dystrophy to identify potential therapies.

Read more